Anterior segment parameters in patients with coronavirus disease

Abstract

Since first identified in December 2019 at Wuhan, China, the coronavirus disease (COVID-19) has become a major public health challenge wordlwide(1). As of September 4, 2020, more than 26 million COVID-19 cases, including 869,600 deaths, were reported in 216 countries(2). The ophthalmological alterations caused by COVID-19 are mainly limited to external ocular diseases such as conjunctivitis(3,4). Therefore, in patients with the infection, we measured anterior segment (AS) parameters, which may show subtle changes in the acute phase of the infection and serve as a tool for monitoring the long-term changes after recovery from COVID-19.